<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> is a well-recognized complication of organ transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>The pattern of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> that occur in the paediatric graft population is different from that in the general paediatric population and in the population of adult organ transplant recipients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We reviewed medical records from 240 consecutive paediatric renal transplantations performed in 219 children, aged less than 19 years, in our centre between April 1987 and March 2007 </plain></SENT>
<SENT sid="3" pm="."><plain>Data from patients who had been transferred into adult units were extracted from the French registries of dialysis and transplantation </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among the 219 children who underwent renal transplantation during the study period, 16 (7.3%) developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The cumulative incidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was 1.9, 4.0, 6.9 and 10.2% at 1, 5, 10 and 15 years post-transplantation, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The 10-year incidence of post-transplantation <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) was 4.5% </plain></SENT>
<SENT sid="7" pm="."><plain>Other identified <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, renal papillary <z:mp ids='MP_0002038'>carcinoma</z:mp>, <z:hpo ids='HP_0002895'>thyroid papillary carcinoma</z:hpo>, recurrent ovarian <z:mpath ids='MPATH_317'>seminoma</z:mpath> and <z:e sem="disease" ids="C0007114" disease_type="Neoplastic Process" abbrv="">skin cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The mortality rate was 25% (4/16) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Early detection of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in transplant recipients is of great importance </plain></SENT>
<SENT sid="10" pm="."><plain>Regular screening for persistent Epstein-Barr virus (EBV) DNA <z:mp ids='MP_0001799'>viral</z:mp> load in patients at risk for developing PTLD is recommended </plain></SENT>
<SENT sid="11" pm="."><plain>The occurrence of <z:e sem="disease" ids="C0007114" disease_type="Neoplastic Process" abbrv="">skin cancer</z:e> in transplanted children is extremely rare during childhood, but cases can develop in early adulthood </plain></SENT>
</text></document>